Surgical Science Sweden AB
OTC:SUSRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
Wall St Price Targets
SUSRF Price Targets Summary
Surgical Science Sweden AB
According to Wall Street analysts, the average 1-year price target for SUSRF is 6.75 USD with a low forecast of 4.59 USD and a high forecast of 9.33 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUSRF's stock price target?
Price Target
6.75
USD
According to Wall Street analysts, the average 1-year price target for SUSRF is 6.75 USD with a low forecast of 4.59 USD and a high forecast of 9.33 USD.
What is the Revenue forecast for Surgical Science Sweden AB?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Surgical Science Sweden AB?
Projected CAGR
12%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Surgical Science Sweden AB?
Projected CAGR
30%
Over the last 10 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 5 years is 30%.
What is the Pre-Tax Income forecast for Surgical Science Sweden AB?
Projected CAGR
33%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Surgical Science Sweden AB?
Projected CAGR
36%
Over the last 10 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 5 years is 36%.
